SCHEMBL6097547

SCHEMBL6097547

CC(C)(C)c1[nH]c2ccccc2c1C1=C(Cl)C(=O)C=C(Cl)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.39
HKDC1 Q2TB90 1/20 0.39
HPGD P15428 2/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNA7 P36544 2/20 0.37
CHRNA4 P43681 2/20 0.37
PTPRC P08575 1/20 0.37
PTGS2 P35354 3/20 0.34
KIF11 P52732 3/20 0.33
LMNA P02545 3/20 0.33
GAA P10253 3/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A2 P05177 3/20 0.32
TNKS2 Q9H2K2 2/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094022 0.83 CCR6 (0.51) CCR6HKDC1HPGDPTGS2LMNA
SCHEMBL29690580 0.83 CCR6 (0.51) CCR6HKDC1HPGDPTGS2LMNA
SCHEMBL6097108 0.80 PTPRC (0.54) HPGDPTPRCPTGS2KDM4EALDH1A1
SCHEMBL6096055 0.80 PTPRC (0.37) CCR6HKDC1HPGDPTPRCPTGS2
SCHEMBL6096197 0.77 OPRM1 (0.35) CCR6HKDC1HPGDPTPRCPTGS2
SCHEMBL6096773 0.76 AURKA (0.34) CCR6HKDC1HPGDPTPRCLMNA
SCHEMBL6096689 0.74 HPGD (0.40) CCR6HKDC1HPGDCHRNB2CHRNA7
SCHEMBL6097015 0.74 MAPT (0.34) CCR6HKDC1PTPRCPTGS2LMNA
SCHEMBL29690625 0.72 CCR6 (0.51) CCR6HKDC1HPGDPTGS2LMNA
SCHEMBL29094066 0.71 CCR6 (0.69) CCR6HKDC1HPGDCHRNB2CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA CCR6 4533/4885HKDC1 2099/4885HPGD 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.